Are Bananas Good for Fatty Liver?

Bananas are good for fatty liver disease as part of a balanced, whole-food diet. Rich in fibre, potassium, and vitamin B6, bananas offer useful nutritional support for people managing metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as NAFLD. They have a moderate glycaemic index, produce a steadier blood sugar response than refined carbohydrates, and count towards your five daily portions of fruit and vegetables. This article explores the evidence behind bananas and liver health, which nutrients matter most, what else to eat or avoid, and when to seek medical advice.

Are bananas good for fatty liver disease?

Bananas are generally suitable for most people with fatty liver disease, as they are low in fat, provide fibre, and have a moderate glycaemic index that supports steadier blood sugar levels.

Bananas are a generally suitable dietary choice for most people with fatty liver disease, as they are low in fat, provide useful fibre, and contain several nutrients that support metabolic health. Fatty liver disease is now formally termed metabolic dysfunction-associated steatotic liver disease (MASLD), though UK resources including NICE and the NHS still widely use the older term non-alcoholic fatty liver disease (NAFLD): both terms refer to the same condition.^[1][15] MASLD is closely linked to poor diet, excess body weight, and insulin resistance. While no single food is a cure, bananas fit well within the broader dietary pattern recommended for liver health.

Bananas have a moderate glycaemic index (GI), meaning they tend to raise blood sugar more gradually than refined carbohydrates such as white bread or sugary drinks, though GI varies with ripeness and portion size. Diabetes UK notes that glycaemic load (which accounts for portion size as well as GI) is a more practical measure than GI alone. Repeated blood sugar spikes and high insulin levels contribute to fat accumulation in the liver, so choosing foods that produce a steadier glucose response is a sensible strategy for people managing fatty liver.

Very ripe bananas have a higher sugar content and a higher GI than less ripe ones. People with fatty liver who also have type 2 diabetes or insulin resistance may wish to opt for slightly firmer, less ripe bananas and to eat them as part of a balanced meal that includes protein or additional fibre, rather than alone. People taking potassium-sparing medicines should seek individual advice from their GP or pharmacist about potassium-rich foods. Overall, bananas are generally suitable for most people with fatty liver as part of a varied, whole-food diet aimed at reducing liver fat.

What does the evidence say about fruit and liver health?

Higher fruit intake is associated with better liver health outcomes, but evidence specific to bananas is limited; whole fruit is preferable to juice or smoothies, which concentrate sugars and raise blood glucose rapidly.

Research consistently suggests that higher fruit and vegetable intake is associated with better liver health outcomes, though much of this evidence comes from observational studies rather than randomised controlled trials, and the evidence specific to bananas is limited. Most studies examine dietary patterns rather than individual foods. A diet rich in whole fruits, vegetables, wholegrains, and lean protein is associated with lower rates of MASLD and slower disease progression, according to NICE guideline NG49 (Non-alcoholic fatty liver disease: assessment and management) and the 2024 EASL-EASD-EASO MASLD clinical practice guideline.

Several observational studies have found that people who consume more dietary fibre and antioxidants, both of which are found in fruit, tend to have lower levels of liver fat and inflammation. The natural sugar in whole fruit (fructose) is accompanied by fibre, water, and micronutrients that slow its absorption and reduce the total free-sugar load reaching the liver. This is a difference in the food matrix and absorption context rather than a difference in how fructose is processed biochemically once absorbed.

It is important to distinguish between whole fruit, smoothies, and fruit juice. Fruit juice removes most of the fibre and concentrates the sugars, which can raise blood glucose rapidly and contribute to liver fat accumulation. Smoothies retain more fibre than juice but still deliver a concentrated sugar load. NHS '5 A Day' guidance advises limiting both fruit juice and smoothies to no more than 150 ml per day, and this counts as only one of your five daily portions regardless of quantity.^[5][6] Eating whole bananas is therefore preferable to drinking banana-based smoothies or juices for people with fatty liver disease. The overall quality of the diet matters far more than any single food, and bananas are best viewed as one component of a liver-friendly eating pattern.

Which nutrients in bananas may support a fatty liver?

Bananas provide potassium, vitamin B6, vitamin C, and dietary fibre, all of which have associative links to metabolic and liver health, though clinical benefit comes from overall dietary quality rather than any single nutrient.

Bananas contain several nutrients that may be beneficial for people with fatty liver disease, including potassium, vitamin B6, vitamin C, and dietary fibre. The evidence for individual nutrients is largely associative and often based on observational data; it is the combination of nutrients within a balanced diet rather than any single nutrient that produces meaningful clinical benefit.

Potassium is important for maintaining healthy blood pressure and reducing the risk of cardiovascular complications, which are a significant concern for people with MASLD. Some observational studies have found an association between low potassium intake and insulin resistance, though this does not establish that potassium supplementation improves liver outcomes.

Vitamin B6 supports amino acid metabolism and has been associated with regulation of homocysteine levels in some research; elevated homocysteine has in turn been linked to liver inflammation in certain studies, though the clinical significance in MASLD specifically remains uncertain.

Dietary fibre, particularly the resistant starch found in less ripe bananas, acts as a prebiotic, feeding beneficial gut bacteria. Emerging evidence suggests that a healthy gut microbiome may reduce liver inflammation and fat deposition, though this area of research is still developing and no firm clinical recommendations for MASLD have yet been established on this basis.

Vitamin C is an antioxidant that may help reduce oxidative stress in liver cells, a key driver of progression from simple fatty liver to more advanced disease such as metabolic dysfunction-associated steatohepatitis (MASH), though again the evidence is largely associative.

According to UK nutrient composition data (McCance and Widdowson's CoFID), a medium banana (approximately 120 g) provides around 3 g of fibre and counts as one of the recommended five daily portions of fruit and vegetables.^[8] These nutritional properties make bananas a practical and accessible food for supporting overall metabolic health as part of a liver-friendly diet, without overstating the benefit of any single nutrient.

What foods should you eat and avoid with fatty liver disease?

A Mediterranean-style diet emphasising vegetables, wholegrains, oily fish, legumes, and olive oil is the most evidence-supported pattern for fatty liver; alcohol, sugary drinks, and ultra-processed foods should be limited or avoided.

A Mediterranean-style diet is the most evidence-supported dietary pattern for people with fatty liver disease, emphasising vegetables, legumes, wholegrains, oily fish, olive oil, nuts, and moderate amounts of fruit, including bananas. Both NICE guideline NG49 and the 2024 EASL-EASD-EASO MASLD guideline highlight dietary modification as a first-line intervention, alongside physical activity and weight management.

Foods to include:

• Vegetables, particularly leafy greens, broccoli, and cruciferous varieties

• Wholegrains such as oats, brown rice, and wholemeal bread

• Oily fish (salmon, mackerel, sardines) for omega-3 fatty acids

• Legumes including lentils, chickpeas, and beans

• Olive oil as the primary cooking fat

• Nuts and seeds in moderate amounts

• Whole fruit, including bananas, berries, and apples

• Coffee, which has been associated with reduced liver fibrosis risk in observational studies, though this is not a basis for increasing intake beyond personal preference^[10]

Foods to limit or avoid:

• Ultra-processed foods high in added sugar, salt, and saturated fat

• Sugary drinks, including fruit juice and fizzy drinks

• Alcohol, which directly damages liver cells and accelerates disease progression

• Red and processed meats in large quantities

• White bread, pastries, and refined carbohydrates

• Foods high in trans fats, such as some commercially fried products

Alcohol deserves particular emphasis. Even in people whose fatty liver is not alcohol-related, alcohol consumption can worsen liver inflammation and fibrosis. The UK Chief Medical Officers' low-risk drinking guidelines advise no more than 14 units per week for adults, spread over three or more days, but people with any form of liver disease should discuss their individual alcohol intake with their GP, as lower limits or complete abstinence may be appropriate.^[4] Portion sizes and overall calorie balance also matter: weight loss of 7 to 10 per cent of body weight has been shown in clinical studies and endorsed by NICE NG49 and the EASL 2024 guideline to significantly reduce liver fat and, with greater weight loss, to improve markers of inflammation and fibrosis.

Can diet alone improve fatty liver, or do you need treatment?

Diet and lifestyle change are the primary treatment for early fatty liver disease, with sustained weight loss of 7 to 10 per cent of body weight shown to reduce liver fat; more advanced disease may require additional medical management.

Diet and lifestyle change can meaningfully improve fatty liver disease, and for many people in the early stages, these measures are the primary treatment recommended by NICE (NG49) and NHS clinicians. Clinical studies and guideline evidence support the finding that sustained weight loss of 7 to 10 per cent of body weight, achieved through dietary change and increased physical activity, can reduce liver fat and lower liver enzyme levels; greater weight loss (above 10 per cent) is associated with improvement in inflammation and, in some cases, early fibrosis, according to the EASL 2024 MASLD guideline.^[1]

However, diet alone may not be sufficient for everyone. People with more advanced disease, such as MASH with significant fibrosis, or those with coexisting conditions such as type 2 diabetes or obesity, may benefit from additional medical management. This can include treatment of underlying metabolic conditions and, where appropriate, specialist referral to a hepatologist or a structured weight management programme.

For people with obesity and fatty liver disease, NICE has issued technology appraisals on certain medicines used as part of a comprehensive weight management approach (including semaglutide and tirzepatide). Access to these medicines on the NHS is subject to eligibility criteria and local integrated care board (ICB) commissioning decisions. A prescriber can assess whether any such treatment is appropriate based on an individual's full clinical picture. Mounjaro (tirzepatide) and Wegovy (semaglutide) are examples of options a prescriber may consider after an online consultation with Bolt Pharmacy, and are only prescribed where clinically appropriate. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support.

Very low-calorie diets and crash diets without medical supervision carry a risk of rapid weight loss, which the EASL guideline cautions may occasionally worsen liver inflammation; gradual, sustained changes to eating habits are therefore preferred. Combined with regular physical activity, this approach offers the most evidence-based path to improving liver health over time.

When should you see a GP about fatty liver disease?

See your GP if you have been diagnosed with fatty liver disease, have risk factors such as obesity or type 2 diabetes, or experience symptoms such as fatigue, upper right abdominal discomfort, or jaundice.

You should see your GP if you have been told you have fatty liver disease (NAFLD or MASLD), if you have risk factors such as obesity, type 2 diabetes, or high cholesterol, or if you experience symptoms that may suggest liver problems. Fatty liver disease is often silent in its early stages and is frequently detected incidentally on an ultrasound or through abnormal liver function blood tests.

Symptoms that warrant a GP appointment include:

• Persistent fatigue or low energy without a clear cause

• Discomfort or a dull ache in the upper right abdomen

• Unexplained weight loss

• Yellowing of the skin or whites of the eyes (jaundice)

• Swelling of the abdomen or legs

• Easy bruising or bleeding

Jaundice, significant abdominal swelling, vomiting blood or passing black tarry stools, or sudden severe confusion alongside liver disease are signs of more serious liver dysfunction and require prompt medical assessment. Contact NHS 111 for urgent advice if you are concerned and cannot reach your GP quickly, or attend accident and emergency if symptoms are severe and develop rapidly.

Your GP can arrange blood tests to assess liver function and calculate a FIB-4 score (a non-invasive marker of liver fibrosis based on age, liver enzymes, and platelet count), in line with NICE NG49.^[2] Depending on the result, further assessment with an Enhanced Liver Fibrosis (ELF) test or a non-invasive assessment of liver stiffness (such as a FibroScan) may be arranged to gauge the degree of fibrosis and determine whether referral to a hepatologist is needed. Regular monitoring is important because fatty liver disease can progress silently over years. Early identification and lifestyle intervention offer the best chance of preventing progression to cirrhosis or liver failure.

If you suspect a side effect from any medicine that may be affecting your liver, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Scientific References

1. EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
2. Metabolic dysfunction-associated steatotic liver disease (NG49): assessment and management.
3. Metabolic dysfunction-associated steatotic liver disease (NG49): recommendations for research.
4. Alcohol consumption: advice on low risk drinking.
5. 5 A Day: what counts?.
6. 5 A Day portion sizes.
7. The Eatwell Guide.
8. Composition of Foods Integrated Dataset (CoFID) — McCance and Widdowson's.
9. Glycaemic Index (GI) — British Dietetic Association.
10. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease (Ebadi M et al.).
11. Tirzepatide for managing overweight and obesity (TA1026).
12. Semaglutide for managing overweight and obesity (TA875).
13. Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations (Ni Y et al.).
14. Dietary Interventions in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review of Evidence, Mechanisms, and Translational Challenges.
15. Global epidemiological patterns and disease burden of MASLD — multisociety Delphi consensus nomenclature.

Frequently Asked Questions